DavidRaymondDroverMD

Anesthesiology • Stanford, CA

Neuroanesthesiology

Professor, Anesthesia, Stanford University Medical Center

Join to view full profile

Dr. Drover is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Drover's full profile

Already have an account?

Office
300 Pasteur Dr
Stanford, CA 94305
Phone+1 650-723-4000

Summary

Dr. David Drover is an anesthesiologist based in Stanford, CA, specializing in neuroanesthesiology. He completed his medical education at Dalhousie University and a fellowship in Clinical Pharmacology at Stanford Health Care, where he has worked as an attending physician since 1995. Dr. Drover has contributed to several publications on topics such as postoperative cognitive decline and pharmacokinetics of fentanyl in surgical patients. Additionally, he has been involved in clinical trials focusing on precision anesthesia, ondansetron metabolism, and neonatal abstinence syndrome.

Education & Training

Stanford Health CareFellowship, Clinical Pharmacology, 1995 - 1997
Dalhousie University Faculty of MedicineClass of 1990
Dalhousie UniversityM.Sc., Clinical Chemistry, 1985 - 1988
Dalhousie UniversityB. Sc., Chemistry, 1980 - 1985

Certifications & Licensure

CA State Medical License 1995 - 2026
FRCP(C)Anesthesiology

Clinical Trials

Postoperative Pain and Functional Patient Outcomes After Functional Endoscopic Sinus Surgery Start of enrollment: 2007 Aug 01
Completed
Phase 4
Using the SEDLine for the Titration of Sevoflurane in Elderly Patients Recovery Using the SEDLine TM for the Titration of Sevoflurane in Elderly Patients Undergoing Non-Cardiac Surgery After Beta-Adrenergic Blockade Start of enrollment: 2006 Jul 01
Completed
Phase 4
Study of Drug Concentration of Ondansetron and Cefazolin in Mothers and Neonates Start of enrollment: 2011 Jan 01
Completed
How Pregnant Women and Their Babies Metabolize Ondansetron Compared to a Group of Non-pregnant Women Start of enrollment: 2013 Jan 01
Completed
Phase 1, Phase 2
Can Ondansetron Prevent Neonatal Abstinence Syndrome (NAS) in Babies Born to Narcotic-dependent Women Start of enrollment: 2014 Sep 09
Completed
Phase 2
Correlate of Surface Electroencephalogram (EEG) With Implanted EEG Recordings (ECOG) Start of enrollment: 2019 Nov 11
Active, not recruiting
Building a Platform for Precision Anesthesia in the Geriatric Surgical Patient Start of enrollment: 2020 Sep 01
Recruiting
Join now to see all

Publications & Presentations

PubMed

An immune signature of postoperative cognitive decline: a prospective cohort study.
Franck Verdonk, Amélie Cambriel, Julien Hedou, Ed Ganio, Grégoire Bellan
International Journal of Surgery. 2024-12-01
AcumenTM hypotension prediction index guidance for prevention and treatment of hypotension in noncardiac surgery: a prospective, single-arm, multicenter trial.
Xiaodong Bao, Sathish S Kumar, Nirav J Shah, Donald Penning, Mitchell Weinstein
Perioperative Medicine. 2024-03-04
Multicenter Population Pharmacokinetics of Fentanyl in Neonatal Surgical Patients Using Dried Blood Spot Specimen Collection Demonstrates Maturation of Elimination Cle...
Rachael S Rzasa Lynn, Thomas K Henthorn, Jeannie Zuk, Gregory B Hammer, David R Drover
Anesthesia and Analgesia. 2024-02-01

Press Mentions

A Specific Brain Function Monitor Could Be Useful During DISENovember 7th, 2024
Masimo Announces Availability of the RD SedLineMarch 6th, 2017
New Study Finds That Masimo SedLine® Patient State Index (PSi) Has the Potential to Improve Brain Monitoring for Patients Sedated with DexmedetomidineAugust 11th, 2023